CLINDAMYCIN KABI
150MG/ML INJ SOL/INF CNC SOL 10X2ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 25.11.2021 | |||
Interruption of marketing | 15.11.2021 |
0129836 |
Capacity/distribution reasons | 22.11.2021 |
Resumption of marketing | 09.11.2021 | |||
Interruption of marketing | 19.10.2021 |
0129836 |
Capacity/distribution reasons | 21.11.2021 |
Placing on the market | 01.03.2009 |
All reports are available in the Overview.